This announcement is a separate document:
回盛生物：中信建投证券股份有限公司关于武汉回盛生物科技股份有限公司及其子公司2024年度向金融机构申请综合授信额度并由实际控制人提供担保暨关联交易的核查意见
Huisheng Biotech: CITIC Construction Investment Securities Co., Ltd.'s inspection opinions on Wuhan Huisheng Biotechnology Co., Ltd. and its subsidiaries applying for comprehensive credit lines from financial institutions in 2024 and having actual controllers provide guarantees and related transactions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.